CCR5 and primary cutaneous T-cell non-Hodgkin lymphoma: The existing evidence indicates that CCR5 is highly expressed in some CTCL skin biopsy samples [39], and RNA-seq data derived from these biopsies further revealed the expression of CCR5 in M2-type TAMs within the TME [38].